The company currently produces two cognitive health products: Edge, for ages 30 to 55, and Revive, for ages over 55.
Its CEO Dr Shawn Watson was a keynote speaker at our recent Healthy Ageing APAC Summit, where he outlined why the traditional pharmaceutical approach to treating cognitive decline, including Alzheimer's, wasn't working.
In our video, he discusses the alternative approaches he thinks deserve greater attention, and reveals two key ingredients that he believes have considerable potential.
He also outlines the importance of educating consumers about cognitive health issues at a younger age, while details why the company is now ready to move to the next level.
Watch the video for more.
